Project Details
Description
A randomized, International, double-blind (internally blinded), gardasil™-controlled, dose-ranging study of tolerability, immunogenicity and efficacy of multivalent virus-like particle (VLP) vaccine against human papillomavirus (HPV) administered to women aged 16 to 26 years.”
| Short title | Protocolo V503-001-04 |
|---|---|
| Status | Finished |
| Effective start/end date | 6/1/14 → 8/1/15 |
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Main Funding Source
- Installed Capacity (Academic Unit)
Location
- South America